INTRODUCTION AND OBJECTIVES: Salvage radiation therapy (SRT) is a therapeutic option for men with PSA rising after radical prostatectomy (RP). While several studies have addressed potential predictors of outcome after SRT, none have investigated the role of the extent of pelvic lymph node dissection (PLND) on SRT outcomes. We hypothesised that cancer control of SRT are improved in men who underwent more extensive PLND at the time of RP.
INTRODUCTION AND OBJECTIVES: Salvage radiation therapy (SRT) is a therapeutic option for men with PSA rising after radical prostatectomy (RP). While several studies have addressed potential predictors of outcome after SRT, none have investigated the role of the extent of pelvic lymph node dissection (PLND) on SRT outcomes. We hypothesised that cancer control of SRT are improved in men who underwent more extensive PLND at the time of RP.
METHODS: The study included 728 patients who received SRT for either PSA rising after RP or PSA persistence after surgery that was defined as PSA level 0.1 ng/ml 1 month after RP. All patients received local radiation to the prostate and seminal vesicle bed at one of six tertiary referral centres; irradiation of the pelvic lymph node region (whole pelvic RT) was left to the discretion of the treating physician. The study outcome consisted of clinical recurrence after SRT as identified by radiologic imaging. Clinical recurrence included pelvic nodal, retroperitoneal nodal, skeletal, and visceral metastasis. Multivariable analysis tested the association between clinical recurrence and the number of lymph nodes removed, which was considered as a continuous variable. Covariates consisted of: pT stage (pT3a vs. pT3b), pathologic Gleason score (7 vs. 8), surgical margin (negative vs. positive), PSA level at SRT, and radiation field (prostatic bed vs. whole pelvis).
RESULTS: Median patient age was 66 years, while the median number of nodes removed at RP was 7 (IQR 0, 13). Overall, 500 (69%) patients received SRT for PSA rising after RP and 228 (31%) were irradiated for PSA persistence. Median PSA at SRT was 0.30 ng/ml. Whole pelvic SRT was delivered to 187 (27%) patients. Median follow-up was 94 months (IQR 48, 128) , during which time. 27 (3.7%), 13 (2.1%), 61 (7.7%), and 11 (1.3%) patients developed pelvic, retroperitoneal, skeletal, and visceral metastasis, respectively. On multivariable analysis, the number of lymph nodes removed at RP was significantly inversely associated with the risk of clinical recurrence following SRT (hazard ratio: 0.97; 95% CI 0.95, 0.99; p¼0.039).
CONCLUSIONS: This is the first study demonstrating a significant inverse correlation between the number of lymph nodes removed and the risk of clinical recurrence after SRT. These data suggest the need for consideration of alternative approaches to management for patients with PSA elevation after RP in whom a lower number of nodes were removed at surgery, including multimodal salvage therapy.
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PD15-12 THE IMPACT OF NERVE SPARING RADICAL PROSTATECTOMY ON ONCOLOGICAL AND FUNCTIONAL OUTCOMES IN PATIENTS WITH HIGH RISK PROSTATE CANCER: A RETROSPECTIVE LONG-TERM SINGLE CENTER STUDY
Marc Alain Furrer*, Tobias Gross, Daniel P. Nguyen, Silvan Boxler, Vera Genitsch, Fiona C. Burkhard, George N. Thalmann, Bern, Switzerland INTRODUCTION AND OBJECTIVES: Whether patients (pts) with high risk prostate cancer (HR PCa) should undergo radical prostatectomy (RP) remains a matter of debate. The aim of the present study was to assess functional and oncological outcomes following RP in pts with HR PCa.
METHODS: We evaluated 316 consecutive pts with HR PCa (according to the NCCN guidelines: pT3a tumor, a PSA level greater than 20 ng/mL, or a Gleason score between 8 and 10) who underwent RP and pelvic lymph node dissection from 1996 to 2015. Continence (CO) and potency (PO) were assessed at 3, 6, 12 and 24 months (mts). Pts who reported absence of erection sufficient for penetration prior to RP were excluded for evaluation of potency. Multivariable logistic regression models tested whether uni-and bilateral nerve sparing (NS) were a predictor of CO or PO at different time points after RP. Occurrence of local recurrence was prospectively entered into our database. For evaluation of positive surgical margins (PSM), pathology reports were retrospectively analyzed together with an uropathologist. RESULTS: At 3, 6, 12, 24 mts, overall continence rates were 87%, 93%, 96% and 98%, respectively. Attempted NS RP was associated with higher continence rates at all time points compared to no NS RP (Fig) . In multivariable analysis, NS was associated with a more than 2.5-fold higher probability of CO at 3 mts (OR 2.74, 95% CI 1.18-6.36, p¼0.02). Overall potency rates were 15%, 31%, 47%, and 50% at 3, 6, 12, and 24 mts, respectively. Attempted nerve sparing RP was associated with higher potency rates at all time points compared to no NS RP (Fig) . In multivariable analysis, NS was associated with a more than 6 to10-fold higher probability of PO at 6, 12 and 24 mts (p<0.0001, p¼0.01 and p¼0.001). The Clavien 30-and 90-day complication rate (p¼0,3 and 0,2) as well as the percentage of major complications (p¼0,2 and 0,1) were not higher in pts with attempted NS compared to pts without attempted NS. Likewise occurrence of PSM and local recurrence were not observed more frequently in pts with attempted NS.
CONCLUSIONS: Attempted NS in pts with HR PCa is associated with higher CO and PO rates after RP without compromising oncological outcome and occurrence of complications.
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